🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
GSK2269557 is a potent and highly selective inhaled Phosphoinositide 3-Kina...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-10
Trial ID
NCT02972905
Treatments Being Tested
This is a randomised, double-blind, placebo controlled, parallel group stud...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-07-31
Trial ID
NCT02130635
Treatments Being Tested
GSK2269557 is potent and highly selective inhaled phosphoinositides 3-kinas...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-01-09
Trial ID
NCT01762878
Treatments Being Tested
GSK2269557 is a potent and highly selective inhaled Phosphoinositide 3-Kina...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-03-14
Trial ID
NCT02691325
Treatments Being Tested